Results 1 to 10 of about 21,978 (256)

Muscle relaxant and antipyretic effects of pentacyclic triterpenes isolated from the roots of Diospyros lotus L [PDF]

open access: yesHeliyon
The present article describes the muscle relaxant and antipyretic effects of pentacyclic triterpenes, oleanolic acid (OA), ursolic acid (UA) and betulinic acid (BA) isolated from roots of Diospyros lotus in animal models.
Ajmal Khan   +10 more
doaj   +4 more sources

Comparison of laryngeal mask airway (LMA) insertion with and without muscle relaxant in pediatric anesthesia; a randomized clinical trial [PDF]

open access: yesHeliyon, 2022
Introduction: This study aimed to evaluate the effectiveness of using muscle relaxant on the ease of laryngeal mask airway (LMA) insertion and possibility of its related complications.
Ziae Totonchi   +4 more
doaj   +4 more sources

Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant [PDF]

open access: yesToxins, 2018
Azemiopsin (Az), a linear peptide from the Azemiops feae viper venom, contains no disulfide bonds, is a high-affinity and selective inhibitor of nicotinic acetylcholine receptor (nAChR) of muscle type and may be considered as potentially applicable ...
Irina V. Shelukhina   +14 more
doaj   +4 more sources

Skeletal muscle relaxant effect of a standardized extract of Valeriana officinalis L. after acute administration in mice

open access: yesJournal of Traditional and Complementary Medicine, 2018
Valeriana officinalis L. root extracts are traditionally taken for their sedative and anxiolytic properties and are also used for muscle relaxation. Relaxant effects were clearly observed on smooth muscle whereas data on effects on skeletal muscle are ...
Dorian Caudal   +7 more
doaj   +4 more sources

Muscle relaxant use and the associated risk of incident frailty in patients with diabetic kidney disease: a longitudinal cohort study [PDF]

open access: yesTherapeutic Advances in Drug Safety, 2021
Background: Patients with diabetic kidney disease (DKD) are at an increased risk of frailty. The exposure to muscle relaxants frequently leads to adverse effects despite their modest therapeutic efficacy, but whether muscle relaxants predispose users to ...
Szu-Ying Lee   +5 more
doaj   +2 more sources

In-vitro antioxidant, lipoxygenase inhibitory, and in-vivo muscle relaxant potential of the extract and constituent isolated from Diospyros kaki (Japanese Persimmon) [PDF]

open access: yesHeliyon, 2023
Diospyros kaki (Japanese persimmon) is cultivated specious of the Diospyros genus. D. kaki is a multi-medicinal application in the folk system for the cure of ischemic stroke, angina, atherosclerosis, muscle relaxation, internal hemorrhage, hypertension,
Adil Mujawah   +5 more
doaj   +2 more sources

Clinical Outcomes of Implementing Two Management Protocols for Acute Respiratory Distress Patients with COVID-19: A Randomized Controlled Trial [PDF]

open access: yesEgyptian Journal of Health Care, 2022
Background: Acute respiratory distress syndrome (ARDS) patients with COVID-19 require sedation or neuromuscular blocking agents to facilitate mechanical ventilation.
Ahmed Talaat Ahmed   +6 more
doaj   +1 more source

Muscle Relaxants Allergy [PDF]

open access: yesInternational Journal of Immunopathology and Pharmacology, 2011
The most common agents that are responsible for intraoperative anaphylaxis are muscle relaxants. In fact, neuromuscular blocking agents (NMBAs) contribute to 50–70% of allergic reactions during anaesthesia. The main mechanism of hypersensitivity reactions to NMBAs is represented by acute type I allergic reactions and the most severe form is anaphylaxis.
PERONI, Diego   +6 more
openaire   +4 more sources

Results of the post-registration clinical study “PARUS” on efficiency and safety assessment of Mydocalm-Richter for local injection therapy of a myofascial trigger zone [PDF]

open access: yesТерапевтический архив, 2018
Aim. The “PARUS” program included investigation of the analgesic, muscle relaxant and sedative effects of Mydocalm-Richter which acts as central muscle relaxant in patients with myofascial pain syndrome, taking into account its registered indication for ...
F I Devlikamova
doaj   +1 more source

Sedation, Analgesia, and Muscle Relaxation During VV-ECMO Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2): A Single-Center, Retrospective, Observational Study

open access: yesFrontiers in Medicine, 2021
Objective: The pharmacokinetics and pharmacodynamics of ECMO-supported sedative, analgesic, and muscle relaxants have changed, but there are insufficient data to determine the optimal dosing strategies for these agents.
Fang Wu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy